Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chi-Ying Huang

24PUBLICATIONS

55CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyEcosystem services (incl. pollination)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Mar 05, 2026

Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screens.

Tiger Haoran Shi, Yu-Tang Huang, Hyunsu Jeon

|Aug 05, 2025

Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.

Han-Hsuan Tang, Chi-Pei Hsu, Pin-Yu Su

|Apr 25, 2025

Correction: Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang

|Feb 26, 2025

Prevention and Treatment of Peritoneal Dialysis-Associated Fibrosis with Intraperitoneal Anti-Fibrotic Therapy in Experimental Peritoneal Fibrosis.

Chiao-Yin Sun, Yu-Ting Hsieh, Shang-Chieh Lu

|Jan 27, 2025

Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang

|Jan 25, 2025

Correction: Yeh et al. Identification of <i>NSP3</i> (<i>SH2D3C</i>) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from <i>Allium sativum</i> L. as Therapeutic Candidates. <i>Biomedicines</i> 2021, <i>9</i>, 1582.

Yuan-Chieh Yeh, Bashir Lawal, Michael Hsiao

Pageof 4

Frequent Collaborators

8 joint publications

Michael Hsiao

3 joint publications

Yuan-Chieh Yeh

2 joint publications

Hsiu-Jung Liao

2 joint publications

Ian Yi-Feng Chang

2 joint publications

Yen-Han Tseng

2 joint publications

Ming-Hsien Chan

2 joint publications

Chun-Li Su

2 joint publications

Trieu Thi My Tran

2 joint publications

Bashir Lawal

2 joint publications

Yu-Chan Chang

Frequent Collaborators

8 joint publications

Michael Hsiao

3 joint publications

Yuan-Chieh Yeh

2 joint publications

Hsiu-Jung Liao

2 joint publications

Ian Yi-Feng Chang

Top Related Videos

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on : Sep 05, 2018

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

See more related videos

Top Related Videos

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on : Sep 05, 2018

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on : Mar 15, 2024

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on : Sep 20, 2016

See more related videos